Amgen posted strong earnings beat and has an attractive dividend, and technical chart forecasting positive future performance ...
Q4 2024 Earnings Call Transcript February 4, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $5.31, expectations were $5.04. Operator: My name is Julienne, and I will be your conference ...
BofA raised the firm’s price target on Amgen (AMGN) to $275 from $256 and keeps an Underperform rating on the shares. Q4 results were slightly ...
Amgen's Q4 2024 earnings show a 19% revenue increase year-on-year, with non-GAAP EPS up 13% in Q4 and 6% for the full year.
Erste Group analyst Hans Engel upgraded Amgen (AMGN) to Buy from Hold. Amgen has a higher operating margin and a higher return on equity than ...
Semafor's signature live journalism event, the 2025 World Economy Summit, will bring together over 200 top CEOs, making it the largest gathering of Fortune 500 leaders hosted in the United States. The ...
All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the ...
The increasing global prevalence of cancer is fueling the demand for peptide-drug conjugates as targeted therapies, providing improved effectiveness and lower systemic toxicity than conventional ...
DelveInsight's Peptide-drug Conjugate Market Insights report provides the current and forecast market analysis, individual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results